retinol and paclitaxel

retinol has been researched along with paclitaxel in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, X; Shao, L; Wang, S; Zhang, H1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Muggia, FM1
Czeczuga-Semeniuk, E; Jarzabek, K; Lemancewicz, D; Wołczyński, S1
Sanusi, RS1

Reviews

1 review(s) available for retinol and paclitaxel

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for retinol and paclitaxel

ArticleYear
Outcome of Combined Neoadjuvant Chemotherapy and Vitamin A in Advanced Cervical Carcinoma: A Randomized Double-Blind Clinical Trial.
    Asian Pacific journal of cancer prevention : APJCP, 2019, 07-01, Volume: 20, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Prognosis; Uterine Cervical Neoplasms; Vitamin A; Vitamins

2019

Other Studies

5 other study(ies) available for retinol and paclitaxel

ArticleYear
CHMIS-C: a comprehensive herbal medicine information system for cancer.
    Journal of medicinal chemistry, 2005, Mar-10, Volume: 48, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Databases, Factual; Internet; National Institutes of Health (U.S.); Neoplasms; Phytotherapy; Plant Preparations; United States; United States Food and Drug Administration

2005
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Vitamin A intoxication during taxol therapy for refractory ovarian cancer.
    Journal of the National Cancer Institute, 1992, Sep-16, Volume: 84, Issue:18

    Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Drug Interactions; Drug Overdose; Female; Humans; Hypervitaminosis A; Middle Aged; Ovarian Neoplasms; Paclitaxel; Vitamin A

1992
The vitamin A family can significantly decrease the expression of ERbeta of ERs positive breast cancer cells in the presence or absence of ER ligands and paclitaxel.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2009, Volume: 25, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; beta Carotene; Breast Neoplasms; Carotenoids; Cell Line, Tumor; Cell Proliferation; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Ligands; Lycopene; Paclitaxel; RNA, Messenger; Tamoxifen; Vitamin A; Vitamins

2009